Cardiol Therapeutics Inc. Class A share price logo

Cardiol Therapeutics Inc. Class A

NASDAQ: CRDL

$1.01

+0.02

(+1.81%)

as on

Cardiol Therapeutics Inc. Class A Stock Performance

as on July 11, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.96
    $1.03
    downward going graph

    4.95%

    Downside

    1.98%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.88
    $1.71
    downward going graph

    12.87%

    Downside

    69.31%

    Upside

    downward going graph

Cardiol Therapeutics Inc. Class A share price movements today

Previous Close
$0.99
Open
$1.01
Volume
746.4K
Day's Low - High
$0.96 - $1.03
52 Week Low - High
$0.88 - $1.71

Cardiol Therapeutics Inc. Class A Historical Returns

1 Month Return
-5.61 %
3 Month Return
-26.81 %
1 Year Return
-21.71 %
3 Year Return
+ 18.82 %
5 Year Return
0 %

Cardiol Therapeutics Inc. Class A Stock Fundamentals & Key Indicators

Check Cardiol Therapeutics Inc. Class A market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$114.4M

EPS (TTM)

-0.36

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-35.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-173.96%

Cardiol Therapeutics Inc. Class A vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cardiol Therapeutics Inc. Class A with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Cardiol Therapeutics Inc. Class A image
Cardiol Therapeutics Inc. Class A
BUY$114.4MNANA0.00%NA
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$23.5B191.53%20.4240.62%NA
Viatris Inc. image
Viatris Inc.
HOLD$19.0B13.7%NA-2.04%2.88%
Haleon plc (ADR) image
Haleon plc (ADR)
BUY$42.8BNA19.8215.11%1.9800000000000002%
ZOETIS INC. image
ZOETIS INC.
BUY$31.5B-61.74%12.3128.04%2.7%
See all

Stock Returns calculator for Cardiol Therapeutics Inc. Class A Stock including INR - Dollar returns

The Cardiol Therapeutics Inc. Class A stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Cardiol Therapeutics Inc. Class A investment value today

Current value as on today

₹87,002

Returns

-₹12,998

(-13%)

Returns from Cardiol Therapeutics Inc. Class A Stock

-₹21,705 (-21.71%)

Dollar Impact

₹8,708 (+8.71%)

Analyst Recommendation on Cardiol Therapeutics Inc. Class A Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Cardiol Therapeutics Inc. Class A. Average target price of $7.2

Cardiol Therapeutics Inc. Class A Share Price Target

Get share price movements and forecasts by analysts on Cardiol Therapeutics Inc. Class A.

What analysts predicted

85.97%UPSIDE

Target Price

$7.2

Current Price

$1.01

Analyzed by

8 Analysts

Target

$7.20

Cardiol Therapeutics Inc. Class A target price $7.2, a slight upside of 85.97% compared to current price of $1.01. According to 8 analysts rating.

Indian Investors' Interest in Cardiol Therapeutics Inc. Class A Stock

Search interest for Cardiol Therapeutics Inc. Class A Stock has increased by 37% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:37% versus previous 30 day period

Cardiol Therapeutics Inc. Class A Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
-
0
-
-
-
0
0
Operating Income
-8
-8
-5
-14
-6
-8
-7
-10
-8
-9
EBITDA
-
-9
-4
-12
-5
-8
-8
-9
-7
-10
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-7
-9
-4
-12
-5
-8
-8
-9
-7
-10
Income Tax Expense
-
0
0
-
-
-
-
-
-
-
Net Income
-5
-6
-3
-9
-3
-5
-8
-9
-7
-10
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cardiol Therapeutics Inc. Class A Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
0
0
-
-
-
-
Gross Profit
0
0
0
0
0
0
-
-
Operating Income
-7
-10
-16
-30
-30
-22
-40
-34
EBITDA
-7
-10
-16
-24
-22
-21
-36
-33
Interest Expense
0
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-15
-10
-16
-25
-22
-21
-36
-33
Income Tax Expense
0
0
0
-6
-10
0
-
-
Net Income
-11
-8
-12
-19
-16
-15
-25
-33
Net Profit Margin
0.00%
0.00%
-20570.94%
-40170.87%
0.00%
0.00%
0.00%
0.00%

Cardiol Therapeutics Inc. Class A Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-9
-6
-12
-8
-8
-8
-9
-7
-10
Operating Cash Flow
-6
-4
-7
-5
-7
-4
-6
-5
-7
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
18
0
0
0
15
13
Change in Cash
-6
-4
-8
14
-7
-5
-6
9
5

Cardiol Therapeutics Inc. Class A Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-15
-13
-20
-31
-30
-28
-36
-33
Operating Cash Flow
-10
-11
-9
-23
-27
-25
-25
-23
Investing Cash Flow
0
0
0
0
0
0
0
0
Financing Cash Flow
25
2
16
93
0
0
18
15
Change in Cash
14
-9
7
69
-24
-24
-4
-9

Global Institutional Holdings in Cardiol Therapeutics Inc. Class A

Funds
Holdings
Mmcap International Inc. Spc
13.32%
Summit Financial LLC
0.09%
Atria Investments LLC
0.12%
1832 Asset Management L.P
0.09%
Virtu Financial LLC
0.13%
See all

Cardiol Therapeutics Inc. Class A News & Key Events

  • img

    Today's Timeline - 13 November

    Thu, 06:15 PM

    -

    Cardiol Therapeutics receives U.S. patent allowance for CardiolRx™ and CRD-38, extending protection until late 2040.

Insights on Cardiol Therapeutics Inc. Class A

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CRDL has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 93.0% return, outperforming this stock by 120.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CRDL stock has moved down by -5.5%

About Cardiol Therapeutics Inc. Class A

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
OrganisationCardiol Therapeutics Inc. Class A
Headquarters2265 Upper Middle Road East, Oakville, ON, Canada, L6H 0G5
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. David G. Elsley MBA
E-voting on sharesClick here to vote

Key Management of Cardiol Therapeutics Inc. Class A

Name

Title

Trevor Burns

Investor Relations

Mr. John A. Geddes BSCPT, MBA

Vice President of Corporate Development

Mr. David G. Elsley MBA

President, CEO & Director

Mr. Christopher J. Waddick C.A., C.M.A., C.P.A., MBA

CFO, Corporate Secretary & Director

Mr. Bernard Lim B.Sc.

Chief Operating Officer

Dr. Andrew Warwick Hamer M.D.

Chief Medical Officer and Head of Research & Development

FAQs

What is Cardiol Therapeutics Inc. Class A share price today?

Cardiol Therapeutics Inc. Class A share price today is $1.01 as on at the close of the market. Cardiol Therapeutics Inc. Class A share today touched a day high of $1.03 and a low of $0.96.

What is the 52 week high and 52 week low for Cardiol Therapeutics Inc. Class A share?

Cardiol Therapeutics Inc. Class A share touched a 52 week high of $1.71 on and a 52 week low of $0.88 on . Cardiol Therapeutics Inc. Class A stock price today i.e. is closed at $1.01,which is 40.94% down from its 52 week high and 14.77% up from its 52 week low.

What is Cardiol Therapeutics Inc. Class A's market capitalisation today?

Cardiol Therapeutics Inc. Class A market capitalisation is $0.00T as on .

How to invest in Cardiol Therapeutics Inc. Class A Stock (CRDL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cardiol Therapeutics Inc. Class A on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cardiol Therapeutics Inc. Class A Shares that will get you 1.4851 shares as per Cardiol Therapeutics Inc. Class A share price of $1.01 per share as on July 11, 2026 at 8:46 am IST.

What is the minimum amount required to buy Cardiol Therapeutics Inc. Class A Stock (CRDL) from India?

Indian investors can start investing in Cardiol Therapeutics Inc. Class A (CRDL) shares with as little as ₹95.37 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.70 in Cardiol Therapeutics Inc. Class A stock (as per the Rupee-Dollar exchange rate as on ). Based on Cardiol Therapeutics Inc. Class A share’s latest price of $1.01 as on July 11, 2026 at 8:46 am IST, you will get 9.9010 shares of Cardiol Therapeutics Inc. Class A. Learn more about fractional shares .